HKSE - Delayed Quote HKD

InnoCare Pharma Limited (9969.HK)

Compare
6.870 -0.040 (-0.58%)
As of 10:05 AM GMT+8. Market Open.
All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Cash Flow
-638,378.000
-671,340.000
-565,554.000
167,058.000
-172,519.000
--
Investing Cash Flow
-1,082,065.000
666,914.000
-1,726,354.000
-1,729,965.000
-1,106,948.000
--
Financing Cash Flow
-32,521.000
1,308.000
3,094,506.000
2,544,807.000
2,237,971.000
--
End Cash Position
3,799,024.000
4,202,564.000
4,179,984.000
3,237,484.000
2,300,881.000
--
Capital Expenditure
-196,923.000
-254,655.000
-370,327.000
-171,211.000
-251,266.000
--
Issuance of Capital Stock
12,365.000
9,947.000
2,923,230.000
2,527,459.000
2,355,855.000
--
Issuance of Debt
31,200.000
33,800.000
325,000.000
50,000.000
--
--
Repayment of Debt
-5,000.000
-2,500.000
--
--
-9,024.000
--
Repurchase of Capital Stock
-16,557.000
-6,300.000
--
--
--
--
Free Cash Flow
-835,301.000
-925,995.000
-935,881.000
-4,153.000
-423,785.000
--
12/31/2019 - 3/23/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers